Keep reading and discover the latest research on testosterone’s benefits
A recent study finds testosterone replacement slows prostate cancer recurrence in low-risk patients
In the most momentous study so far undertaken, US researchers have found that testosterone replacement slows the return of prostate cancer in low-risk patients.
This finding may question the long-held theory of traditional hormonal prostate treatment. The conclusions were presented at the European Association of Urology congress in Barcelona, Spain.
Doctors have long regarded testosterone as a hormone which promotes prostate cancer. The 1941 work of Dr. Charles Huggins and Clarence Hodges won Huggins the 1966 Nobel Prize for Medicine, for reporting the dramatic impact of testosterone reduction on prostate cancer.
Since then, medicines which reduce levels of the hormone testosterone have become a standard option for many patients.
But the Huggins study has been shown to be severely flawed.
In the late 1990s to 2000s, doctors observed that although men on long term anti-testosterone treatments were not dying from prostate cancer, they were dying prematurely of cardiovascular disease.
It seemed that although anti-testosterone therapies were treating the prostate cancer, the deficient testosterone levels were significantly worsening a parade of metabolic dysfunctions: elevated blood sugar, diabetes, high cholesterol, mid-abdomen visceral fat, fatigue, weakened, shrinking muscles, etc.
Low testosterone also caused a loss of libido and sexual ability in many men on Low-T treatment. This led some doctors to propose testosterone treatment of some low-risk men after radiation or surgical treatment.
Beginning in 2008 a team of doctors from the University of California, Irvine, led by Professor Thomas Ahlering, began to carefully select patients for testosterone replacement after primary treatment of prostate cancer with robotic radical prostatectomy, in hopes of improving recovery of sexual function.
The team worked with 834 patients undergoing radical prostatectomy. They treated 152 low-risk patients with no evidence of disease with testosterone replacement therapy.
After a median of 3.1 years following surgery, the patients were tested for biochemical recurrence of cancer, as indicated by measurement of the Prostate Specific Antigen (PSA) levels.
They found that cancer had recurred in only approximately 5% of treated patients, whereas cancer had recurred in 15% of the patients who did not receive testosterone. Overall, after accounting for differences between the groups, they found nearly a three-fold reduction by three years.
The Significance of the Study
Thomas Ahlering stated that, "This is not what we set out to prove, so it was a big surprise: not only did testosterone replacement not increase recurrence, but it actually lowered recurrence rates. While the testosterone is not curing the cancer per se, it is slowing the growth of the cancer, giving an average of an extra 1.5 years before traces of cancer can be found. We already know that testosterone can help with physiological markers such as muscle mass, better cholesterol and triglyceride levels, and increased sexual activity, so this seems to be a win-win".
He continued, "There have been smaller studies which have hinted that testosterone may not be risky for certain patient groups, but this is the largest such study ever conducted. We're not suggesting that treatment methods be changed just yet, but this puts us at the stage where we need to question the taboo against testosterone use in prostate cancer therapy -- especially for low-risk patients after radical prostatectomy. We need the oncology/urology community to begin to review testosterone use".
Professor Francesco Montorsi (Milano), European Association of Urology's Adjunct Secretary General for Science said:
"The paper is indeed important, as it stresses the importance of checking testosterone levels as a part of the management of patients with sexual disorders following radical prostatectomy. Obviously selection of the right patients is vital, but if confirmed, this may have immediate benefits on quality of life; the possibility of reducing mortality would be an unexpected bonus. We now need bigger studies to support this work".
This is an objective observation. Professor Montorsi was not directly involved in this work.
Contact Us Today For A Free Consultation
Once you have completing the above contact form, for security purposes and confirmation, please confirm your information by calling us.
Please call now: 1-800-380-5339.
Welcoming You To Our Clinic, Professor Tom Henderson.
- Systems to Monitor Testosterone Replacement Therapy (TRT) - September 21st, 2022
- Safe Tlando Testosterone Changes Landscape of Low-T Therapy - August 15th, 2022
- Tlando Testosterone - A Brand New Way to Treat Low-T Safely with a Testosterone Pill - July 12th, 2022
- The many benefits of Testosterone Replacement Therapy (TRT) - June 13th, 2022
- Testosterone Therapy Increasingly Used to Help Men Take Control of Aging - May 30th, 2022
- How Does Masturbation Affect Testosterone Levels? Exploring the Science - March 27th, 2022
- Growth Hormone and The Thyroid Gland - November 19th, 2021
- How Testosterone Impacts Sexual Preferences In Men and Women - October 30th, 2021
- Testosterone FAQ's - October 25th, 2021
- Why You Need Testosterone Replacement Therapy - October 16th, 2021
- Testosterone Battles Obesity - October 16th, 2021
- Testosterone and Male Menopause - October 16th, 2021
- Testosterone Replacement Therapy (TRT) Benefits - October 16th, 2021
- Testosterone and Aging - October 16th, 2021
- Testosterone and Estrogen - October 16th, 2021
- Judge Vacates $140 Million Verdict in Testosterone Lawsuit - October 15th, 2021
- Testosterone and Disease Prevention - October 15th, 2021
- Testosterone and Metabolic Syndrome - October 15th, 2021
- Testosterone and Women - October 15th, 2021
- Testosterone Does Not Cause Heart Attacks - October 15th, 2021
- Free Testosterone and Sex Hormone-Binding Globulin - October 15th, 2021
- Research proves that Testosterone Therapy Boosts Fertility! - September 26th, 2021
- New Study Concludes: Boosting Testosterone Levels Lowers Men's Death Risk - August 20th, 2021
- In the Battle Against Aging, When do the Risks Outweigh the Rewards? - August 18th, 2021
- A Recent Study Concludes: Testosterone DOES NOT Cause Prostate Cancer - August 16th, 2021
- Testosterone Therapy May Be Good for the Heart if You Have Low-T - July 21st, 2021
- Low-T: What are healthy levels of Testosterone and why is it difficult to measure? - April 3rd, 2021
- Testosterone: How Much Do You Really Know About This Masculine Hormone? - February 9th, 2021
- Male Menopause. Fact or Fiction ? - January 20th, 2021
- New Study Says: The Benefits of Testosterone Replacement Therapy Outweigh The Risks - January 19th, 2021
- Testosterone Replacement Therapy Lowers Heart Attack Risk - January 18th, 2021
- The Great Testosterone Debate - January 14th, 2021
- New Study Finds Testosterone Does Not Increase Your Heart Attack Risk - January 11th, 2021
- Did You Know? Recent Studies Have Confirmed the Link Between Low Testosterone (“Low-T”) and Depression. - January 10th, 2021
- Testosterone Replacement Therapy (TRT) May Prevent Heart Attacks and Diabetes - November 17th, 2020
- Testosterone Treatments May Successfully Reverse Type-2 Diabetes in Some Men - November 13th, 2020
- Important Facts About Testosterone Therapy Before Buying - July 13th, 2019
- LabCorp Announces a Change to the Testosterone Reference Range - June 23rd, 2019